Compare PCRX & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | GFR |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 924.7M |
| IPO Year | 2010 | 2023 |
| Metric | PCRX | GFR |
|---|---|---|
| Price | $25.17 | $5.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $30.00 | $7.75 |
| AVG Volume (30 Days) | 464.2K | ★ 1.4M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $3.85 | N/A |
| Revenue Next Year | $4.69 | $99.34 |
| P/E Ratio | $131.63 | ★ $4.33 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $4.15 |
| 52 Week High | $27.66 | $7.16 |
| Indicator | PCRX | GFR |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 45.88 |
| Support Level | $24.61 | $5.54 |
| Resistance Level | $25.17 | $6.09 |
| Average True Range (ATR) | 0.81 | 0.27 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 68.40 | 27.95 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.